RESUMO
This paper describes the structure-activity-relationships of novel fluoroalkyl substituents at the C2 position of iminothiazine dioxide beta secretase inhibitors. Key discoveries include reduced amidine basicity and its effect on Pgp, cell potency, and efficacy in various preclinical in vivo efficacy animal models. Findings from these structure-activity-relationships are discussed.
Assuntos
Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Ácido Aspártico Endopeptidases/antagonistas & inibidores , Descoberta de Drogas , Inibidores Enzimáticos/farmacologia , Óxidos/farmacologia , Tiazinas/farmacologia , Administração Oral , Secretases da Proteína Precursora do Amiloide/metabolismo , Animais , Ácido Aspártico Endopeptidases/metabolismo , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/química , Células HEK293 , Humanos , Estrutura Molecular , Óxidos/administração & dosagem , Óxidos/química , Ratos , Relação Estrutura-Atividade , Tiazinas/administração & dosagem , Tiazinas/químicaRESUMO
Although π-conjugated two dimensional (2D) covalent organic frameworks (COFs) have been extensively reported, developing fully π-conjugated 3D COFs is still an extremely difficult problem due to the lack of fully π-conjugated 3D linkers. We synthesize a fully conjugated 3D COF (BUCT-COF-1) by designing a saddle-shaped building block of aldehyde-substituted cyclooctatetrathiophene (COThP)-CHO. As a consequence of the fully conjugated 3D network, BUCT-COF-1 demonstrates ultrahigh Hall electron mobility up to ≈3.0â cm2 V-1 s-1 at room temperature, which is one order of magnitude higher than the current π-conjugated 2D COFs. Temperature-dependent conductivity measurements reveal that the charge carriers in BUCT- COF-1 exhibit the band-like transport mechanism, which is entirely different from the hopping transport phenomena observed in common organic materials. The findings indicate that fully conjugated 3D COFs can achieve electron delocalization and charge-transport pathways within the whole 3D skeleton, which may open up a new frontier in the design of organic semiconducting materials.
RESUMO
PURPOSE: Performance of a transdermal delivery system (TDS) can be affected by exposure to elevated temperature, which can lead to unintended safety issues. This study investigated TDS and skin temperatures and their relationship in vivo, characterized the effective thermal resistance of skin, and identified the in vitro diffusion cell conditions that would correlate with in vivo observations. METHODS: Experiments were performed in humans and in Franz diffusion cells with human cadaver skin to record skin and TDS temperatures at room temperature and with exposure to a heat flux. Skin temperatures were regulated with two methods: a heating lamp in vivo and in vitro, or thermostatic control of the receiver chamber in vitro. RESULTS: In vivo basal skin temperatures beneath TDS at different anatomical sites were not statistically different. The maximum tolerable skin surface temperature was approximately 42-43°C in vivo. The temperature difference between skin surface and TDS surface increased with increasing temperature, or with increasing TDS thermal resistance in vivo and in vitro. CONCLUSIONS: Based on the effective thermal resistance of skin in vivo and in vitro, the heating lamp method is an adequate in vitro method. However, the in vitro-in vivo correlation of temperature could be affected by the thermal boundary layer in the receiver chamber.
Assuntos
Nicotina/química , Absorção Cutânea , Temperatura Cutânea , Administração Cutânea , Adulto , Difusão , Feminino , Temperatura Alta , Humanos , Técnicas In Vitro , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Nicotina/metabolismo , Permeabilidade , Dispositivos para o Abandono do Uso de Tabaco , Adesivo TransdérmicoRESUMO
A convenient and efficient in vitro diffusion cell method to evaluate formulations for inner ear delivery via the intratympanic route is currently not available. The existing in vitro diffusion cell systems commonly used to evaluate drug formulations do not resemble the physical dimensions of the middle ear and round window membrane. The objectives of this study were to examine a modified in vitro diffusion cell system of a small diffusion area for studying sustained release formulations in inner ear drug delivery and to identify a formulation for sustained drug delivery to the inner ear. Four formulations and a control were examined in this study using cidofovir as the model drug. Drug release from the formulations in the modified diffusion cell system was slower than that in the conventional diffusion cell system due to the decrease in the diffusion surface area of the modified diffusion cell system. The modified diffusion cell system was able to show different drug release behaviors among the formulations and allowed formulation evaluation better than the conventional diffusion cell system. Among the formulations investigated, poly(lactic-co-glycolic acid)-poly(ethylene glycol)-poly(lactic-co-glycolic acid) triblock copolymer systems provided the longest sustained drug delivery, probably due to their rigid gel structures and/or polymer-to-cidofovir interactions.
Assuntos
Citosina/análogos & derivados , Portadores de Fármacos/química , Orelha Interna/metabolismo , Orelha Média/metabolismo , Modelos Biológicos , Organofosfonatos/administração & dosagem , Polietilenoglicóis/química , Poliglactina 910/química , Química Farmacêutica/métodos , Cidofovir , Simulação por Computador , Citosina/administração & dosagem , Citosina/química , Citosina/farmacocinética , Preparações de Ação Retardada , Liberação Controlada de Fármacos , Orelha Interna/efeitos dos fármacos , Orelha Média/efeitos dos fármacos , Membranas Artificiais , Organofosfonatos/química , Organofosfonatos/farmacocinéticaRESUMO
PURPOSE: ß-Blockers have recently become the main form of treatment of infantile hemangiomas. Due to the potential systemic adverse effects of ß-blockers, topical skin treatment of the drugs is preferred. However, the effect and mechanism of dosage form pH upon skin permeation of these weak bases is not well understood. To develop an effective topical skin delivery system for the ß-blockers, the present study evaluated skin permeation of ß-blockers propranolol, betaxolol, timolol, and atenolol. METHODS: Experiments were performed in side-by-side diffusion cells with human epidermal membrane (HEM) in vitro to determine the effect of donor solution pH upon the permeation of the ß-blockers across HEM. RESULTS: The apparent permeability coefficients of HEM for the ß-blockers increased with their lipophilicity, suggesting the HEM lipoidal pathway as the main permeation mechanism of the ß-blockers. The pH in the donor solution was a major factor influencing HEM permeation for the ß-blockers with a 2- to 4-fold increase in the permeability coefficient per pH unit increase. This permeability versus pH relationship was found to deviate from theoretical predictions, possibly due to the effective stratum corneum pH being different from the pH in the donor solution. CONCLUSIONS: The present results suggest the possibility of topical treatment of hemangioma using ß-blockers.
Assuntos
Antagonistas Adrenérgicos beta/farmacocinética , Atenolol/farmacocinética , Betaxolol/farmacocinética , Propranolol/farmacocinética , Pele/metabolismo , Timolol/farmacocinética , Administração Tópica , Antagonistas Adrenérgicos beta/química , Adulto , Atenolol/química , Betaxolol/química , Epiderme/metabolismo , Humanos , Pessoa de Meia-Idade , Propranolol/química , Absorção Cutânea , Timolol/química , Adulto JovemRESUMO
Antagonism of the adenosine A(2A) receptor affords a possible treatment of Parkinson's disease. In the course of investigating pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A(2A) antagonists, we prepared [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones with potent and selective (vs A(1)) A(2A) antagonist activity. Structure-activity relationships are described for this series.
Assuntos
Antagonistas do Receptor A2 de Adenosina/química , Receptor A2A de Adenosina/química , Antagonistas do Receptor A2 de Adenosina/síntese química , Antagonistas do Receptor A2 de Adenosina/uso terapêutico , Humanos , Doença de Parkinson/tratamento farmacológico , Pirimidinonas/síntese química , Pirimidinonas/química , Pirimidinonas/uso terapêutico , Receptor A2A de Adenosina/metabolismo , Relação Estrutura-AtividadeRESUMO
Chronic wounds remain a significant public problem and the development of wound treatments has been a research focus for the past few decades. Despite advances in the products derived from endogenous substances involved in a wound healing process (e.g., growth factors, stem cells, and extracellular matrix), effective and safe wound therapeutics are still limited. There is an unmet need to develop new therapeutics. Various new pathways and targets have been identified and could become a molecular target in designing novel wound agents. Importantly, many existing drugs that target these newly identified pathways could be repositioned for wound therapy, which will facilitate fast translation of research findings to clinical applications. This review discusses the newly identified pathways/targets and their potential uses in the development of wound therapeutics. Some herbs and amphibian skins have been traditionally used for wound repairs and their active ingredients have been found to act in these new pathways. Hence, screening these natural products for novel wound therapeutics remains a viable approach. The outcomes of wound care using natural wound therapeutics could be improved if we can better understand their cellular and molecular mechanisms and fabricate them in appropriate formulations, such as using novel wound dressings and nano-engineered materials. Therefore, we also provide an update on the advances in wound therapeutics from natural sources. Overall, this review offers new insights into novel wound therapeutics.
Assuntos
Produtos Biológicos , Cicatrização , Bandagens , Produtos Biológicos/uso terapêutico , PeleRESUMO
PURPOSE: The objectives of this study were to determine the effects of permeant lipophilicity on permeant uptake into and transport across human sclera for transscleral delivery. METHODS: Model permeants with a wide range of lipophilicities were selected and studied with human sclera. Uptake experiments were carried out to measure permeant partitioning into the sclera. Transport experiments were performed in side-by-side diffusion cells, and the permeability coefficients and transport lag times of the permeants across the sclera were evaluated. RESULTS: Permeants with higher lipophilicity showed higher partition coefficients to human sclera, and the apparent transport lag time also increased significantly as the permeant lipophilicity increased. No correlation between the permeability coefficients and lipophilicity of the model permeants was observed in this study with human sclera. A hypothesis on the different findings between the present and previous studies was proposed. CONCLUSIONS: Permeants with higher lipophilicity exhibited stronger binding to human sclera and would therefore lead to larger permeant partitioning to the sclera and longer transport lag time. The steady-state permeability coefficients of the permeants were not significantly affected by permeant lipophilicity.
Assuntos
Esclera/metabolismo , Idoso , Humanos , Pessoa de Meia-Idade , PermeabilidadeRESUMO
Experimental conditions that could impact the evaluation of heat effects on transdermal delivery systems (TDS) using an in vitro permeation test (IVPT) and in vitro release testing (IVRT) were examined. Fentanyl was the model TDS. IVPT was performed using Franz diffusion cell, heating lamp, and human skin with seven heat application regimens. IVRT setup was similar to IVPT, without using skin. Dissolution study was conducted in a modified dissolution chamber. The activation energy of skin permeation for fentanyl was determined using aqueous solution of fentanyl. In IVPT, the increase of temperature from 32 °C to 42 °C resulted in a 2-fold increase in flux for fentanyl TDS, consistent with the activation energy determined. The magnitude of flux increase was affected by the heat exposure onset time and duration: higher flux was observed when heat was applied earlier or following sustained heat application. Heat induced flux increases could not be observed when inadequate sampling time points were used, suggesting the importance of optimizing sampling time points. Drug release from TDS evaluated using IVRT was fast and the skin was the rate-limiting barrier for TDS fentanyl delivery under elevated temperature.
Assuntos
Fentanila , Absorção Cutânea , Administração Cutânea , Sistemas de Liberação de Medicamentos , Temperatura Alta , Humanos , Permeabilidade , Pele/metabolismoRESUMO
A computational model was developed to better understand the impact of elevated skin temperatures on transdermal drug delivery and dermal clearance. A simultaneous heat and mass transport model with emphasis on transdermal delivery system (TDS) applications was developed to address transient and steady-state temperature effects on dermal absorption. The model was tested using representative data from nicotine TDS applied to human skin either in vitro or in vivo. The approximately 2-fold increase of nicotine absorption with a 10°C increase in skin surface temperature was consistent with a 50-65 kJ/mol activation energy for diffusion in the stratum corneum, with this layer serving as the primary barrier for nicotine absorption. Incorporation of a dermal clearance component into the model revealed efficient removal of nicotine via the dermal capillaries at both normal and elevated temperatures. Two-compartment pharmacokinetic simulations yielded systemic drug concentrations consistent with the human pharmacokinetic data. Both in vitro skin permeation and in vivo pharmacokinetics of nicotine delivered from a marketed TDS under normal and elevated temperatures can be satisfactorily described by a simultaneous heat and mass transfer computational model incorporating realistic skin barrier properties and dermal clearance components.
Assuntos
Nicotina/administração & dosagem , Nicotina/metabolismo , Modelagem Computacional Específica para o Paciente , Absorção Cutânea/efeitos dos fármacos , Temperatura Cutânea/efeitos dos fármacos , Administração Cutânea , Administração Tópica , Capilares/efeitos dos fármacos , Capilares/metabolismo , Humanos , Taxa de Depuração Metabólica/efeitos dos fármacos , Taxa de Depuração Metabólica/fisiologia , Absorção Cutânea/fisiologia , Temperatura Cutânea/fisiologia , Adesivo TransdérmicoRESUMO
A combined experimental and computational model approach was developed to assess heat effects on drug delivery from transdermal delivery systems (TDSs) in vitro and nicotine was the model drug. A Franz diffusion cell system was modified to allow close control of skin temperature when heat was applied from an infrared lamp in vitro. The effects of different heat application regimens on nicotine fluxes from two commercial TDSs across human cadaver skin were determined. Results were interpreted in terms of transport parameters estimated using a computational heat and mass transport model. Steady-state skin surface temperature was obtained rapidly after heat application. Increasing skin surface temperature from 32 to 42°C resulted in an approximately 2-fold increase in average nicotine flux for both TDSs, with maximum flux observed during early heat application. ANOVA statistical analyses of the in vitro permeation data identified TDS differences, further evidenced by the need for a two-layer model to describe one of the TDSs. Activation energies associated with these data suggest similar temperature effects on nicotine transport across the skin despite TDS design differences. Model simulations based on data obtained from continuous heat application were able to predict system response to intermittent heat application, as shown by the agreement between the simulation results and experimental data of nicotine fluxes under four different heat application regimens. The combination of in vitro permeation testing and a computational model provided a parameter-based heat and mass transport approach to evaluate heat effects on nicotine TDS delivery.
Assuntos
Simulação por Computador , Sistemas de Liberação de Medicamentos/métodos , Temperatura Alta , Modelos Biológicos , Nicotina/administração & dosagem , Absorção Cutânea/efeitos dos fármacos , Administração Cutânea , Idoso , Transporte Biológico/efeitos dos fármacos , Transporte Biológico/fisiologia , Avaliação Pré-Clínica de Medicamentos/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Nicotina/metabolismo , Técnicas de Cultura de Órgãos , Absorção Cutânea/fisiologia , Adesivo TransdérmicoRESUMO
Electrically assisted delivery is noninvasive and has been investigated in a number of ocular drug delivery studies. The objectives of this study were to examine the feasibility of electrically assisted delivery of macromolecules such as small interfering RNA (siRNA) into the corneal epithelium, to optimize the iontophoresis and electroporation methods, and to study the mechanisms of corneal iontophoresis for macromolecules. Anodal and cathodal iontophoresis, electroporation and their combinations were the methods examined with mice in vivo. Cyanine 3 (Cy3)-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) siRNA and fluorescein isothiocyanate (FITC)-labeled dextran of different molecular weights (4-70 kDa) were the macromolecules studied. Microscopy and histology after cryostat sectioning were used to analyze and compare the delivery of the macromolecules to the cornea. Iontophoresis was effective in delivering siRNA and dextran up to 70 kDa into the cornea. The electroporation method studied was less effective than that of iontophoresis. Although both iontophoresis and electroporation alone can deliver the macromolecules into the cornea, these methods alone were not as effective as the combination of iontophoresis and electroporation (iontophoresis followed by electroporation). The significant enhancement of dextran delivery in anodal iontophoresis suggests that electroosmosis can be a significant flux-enhancing mechanism during corneal iontophoresis. These results illustrate the feasibility of electrically assisted delivery of macromolecules such as siRNA into the cornea.
Assuntos
Eletroporação/métodos , Epitélio Corneano/metabolismo , Iontoforese/métodos , Substâncias Macromoleculares/administração & dosagem , Animais , Dextranos/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Estudos de Viabilidade , Técnicas de Transferência de Genes , Gliceraldeído-3-Fosfato Desidrogenases/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , RNA Interferente Pequeno/genéticaRESUMO
PURPOSE: Transport across the human nail under hydration can be modeled as hindered transport across aqueous pore pathways. As such, nail permselectivity to charged species can be manipulated by changing the ionic strength of the system in transungual delivery to treat nail diseases. The present study investigated the effects of ionic strength upon transungual passive and iontophoretic transport. METHODS: Transungual passive and anodal iontophoretic transport experiments of tetraethylammonium ion (TEA) were conducted under symmetric conditions in which the donor and receiver had the same ionic strength in vitro. Experiments under asymmetric conditions were performed to mimic the in vivo conditions. Prior to the transport studies, TEA uptake studies were performed to assess the partitioning of TEA into the nail. RESULTS: Permselectivity towards TEA was inversely related to ionic strength in both passive and iontophoretic transport. The permeability and transference number of TEA were higher at lower ionic strengths under the symmetric conditions due to increased partitioning of TEA into the nail. Transference numbers were smaller under the asymmetric conditions compared with their symmetric counterparts. CONCLUSIONS: The results demonstrate significant ionic strength effects upon the partitioning and transport of a cationic permeant in transungual transport, which may be instrumental in the development of transungual delivery systems.
Assuntos
Iontoforese , Unhas/metabolismo , Tetraetilamônio/farmacocinética , Adulto , Idoso , Idoso de 80 Anos ou mais , Transporte Biológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Concentração Osmolar , Tetraetilamônio/química , Água/metabolismo , Adulto JovemRESUMO
Antagonism of the adenosine A(2a) receptor offers great promise in the treatment of Parkinson's disease. In the course of exploring pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A(2A) antagonists, which led to clinical candidate SCH 420814, we prepared 1,2,4-triazolo[1,5-c]pyrimidines with potent and selective (vs A(1)) A(2a) antagonist activity, including oral activity in the rat haloperidol-induced catalepsy model. Structure-activity relationships and plasma levels are described for this series.
Assuntos
Antagonistas do Receptor A2 de Adenosina , Doença de Parkinson/tratamento farmacológico , Pirimidinas/farmacologia , Triazóis/síntese química , Administração Oral , Animais , Área Sob a Curva , Catalepsia , Química Farmacêutica/métodos , Desenho de Fármacos , Haloperidol/farmacologia , Modelos Químicos , Pirimidinas/síntese química , Pirimidinas/química , Ratos , Relação Estrutura-Atividade , Triazóis/farmacologiaRESUMO
Effective and safe treatment of auditory and vestibular diseases has become increasingly dependent on inner ear drug delivery systems. This review highlights recent advances in inner ear drug delivery research and technologies. The focus is on strategies to overcome delivery barriers and to improve drug residence and targeting, with special attention to in vivo animal and human studies. The research in gene and stem cell delivery to the inner ear is briefly reviewed. Newly developed research tools to address experimental challenges and safety issues are discussed. Local drug delivery to the inner ear with non-invasive or minimally invasive approaches still remains challenging. Nanocarrier-based systems with sustained and targeted delivery properties may be promising for future clinical applications. Precisely controlled intratympanic and intracochlear administration with minimized trauma to the delicate inner ear represents the future perspective in inner ear drug research and development. Trans-oval window delivery may be promising as it allows direct delivery of drugs to the vestibule for vestibular disorders while avoiding the undesired effects due to drug distribution to the cochlea.
Assuntos
Portadores de Fármacos/química , Orelha Interna , Doenças do Labirinto/tratamento farmacológico , Nanopartículas/química , Preparações Farmacêuticas/administração & dosagem , Animais , Cóclea/metabolismo , Preparações de Ação Retardada , Vias de Administração de Medicamentos , HumanosRESUMO
Transungual iontophoretic transport of model neutral permeants mannitol (MA), urea (UR), and positively charged permeant tetraethylammonium ion (TEA) across fully hydrated human nail plates at pH 7.4 were investigated in vitro. Four protocols were involved in the transport experiments with each protocol divided into stages including passive and iontophoresis transport of 0.1 and 0.3 mA. Water and permeant uptake experiments of nail clippings were also conducted to characterize the hydration and binding effects of the permeants to the nails. Iontophoresis enhanced the transport of MA and UR from anode to cathode, but this effect (electroosmosis) was marginal. The transport of TEA was significantly enhanced by anodal iontophoresis and the experimental enhancement factors were consistent with the Nernst-Planck theory predictions. Hindered transport was also observed and believed to be critical in transungual delivery. The barrier of the nail plates was stable over the time course of the study, and no significant electric field-induced alteration of the barrier was observed. The present results with hydrated nail plates are consistent with electrophoresis-dominant (the direct field effect) transungual iontophoretic transport of small ionic permeants with small contribution from electroosmosis.
Assuntos
Eletro-Osmose , Eletroforese , Iontoforese , Manitol/farmacocinética , Unhas/metabolismo , Compostos de Tetraetilamônio/farmacocinética , Transporte Biológico , Humanos , Doenças da Unha/tratamento farmacológico , PermeabilidadeRESUMO
Previous investigations in our laboratory demonstrated how the polar head group and alkyl chain of amphiphilic chemical skin permeation enhancers contribute to enhancer potency. In those studies enhancers with n-alkyl chain lengths of eight or less were investigated. In order to investigate enhancers with longer n-alkyl chain lengths, enhancer-solubilizing agents should be considered. Corticosterone (CS) flux enhancement along the lipoidal pathway of hairless mouse skin (HMS) was determined with the enhancers 1-hexyl- (HP), 1-octyl- (OP), 1-decyl- (DP), and 1-dodecyl-2-pyrrolidone (DoP) solubilized in 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-[methoxy(polyethylene glycol-2000] (DSPE) micelles or in hydroxypropyl-beta-cyclodextrin (HPbetaCD). The free CS, HP, OP, DP, and DoP aqueous concentrations in the DSPE micelle and HPbetaCD systems were determined using a partitioning method. Comparisons of the enhancer potencies based on the free concentration of the enhancers revealed a nearly semi-logarithmic linear relationship between enhancer potency and the carbon number of the alkyl chain length with a slope of approximately 0.55. The observed n-alkyl chain length dependency in the aqueous phase is consistent with the hydrophobic effect. This study shows that longer chain enhancers may be studied by employing a solubilizing system, and free enhancer concentration in these systems can be determined with the aid of the silicone elastomer uptake method.
Assuntos
Excipientes/farmacologia , Pirrolidinonas/farmacologia , Elastômeros de Silicone , Absorção Cutânea/efeitos dos fármacos , beta-Ciclodextrinas/química , 2-Hidroxipropil-beta-Ciclodextrina , Algoritmos , Animais , Transporte Biológico Ativo , Fenômenos Químicos , Química Farmacêutica , Físico-Química , Corticosterona/administração & dosagem , Corticosterona/farmacocinética , Feminino , Camundongos , Micelas , Permeabilidade , Pirrolidinonas/farmacocinética , Pele/anatomia & histologia , Pele/química , Relação Estrutura-AtividadeRESUMO
Transungual transport is hindered by the inherent small effective pore size of the nail even when it is fully hydrated. The objectives of this study were to determine the effects of chemical enhancers thioglycolic acid (TGA), glycolic acid (GA), and urea (UR) on transungual transport and iontophoresis efficiency. In vitro passive and iontophoretic transport experiments of model permeants mannitol (MA), UR, and tetraethylammonium (TEA) ion across the fully hydrated, enhancer-treated and untreated human nail plates were performed in phosphate-buffered saline. The transport experiments consisted of several stages, alternating between passive and anodal iontophoretic transport at 0.1mA. Nail water uptake experiments were conducted to determine the water content of the enhancer-treated nails. The effects of the enhancers on transungual electroosmosis were also evaluated. Nails treated with GA and UR did not show any transport enhancement. Treatment with TGA at 0.5M enhanced passive and iontophoretic transungual transport of MA, UR, and TEA. Increasing the TGA concentration to 1.8M did not further increase TEA iontophoresis efficiency. The effect of TGA on the nail plates was irreversible. The present study shows the possibility of using a chemical enhancer to reduce transport hindrance in the nail plate and thus enhance passive and iontophoretic transungual transport.
Assuntos
Excipientes/farmacologia , Iontoforese/métodos , Unhas/metabolismo , Idoso , Idoso de 80 Anos ou mais , Difusão , Eletro-Osmose , Humanos , Umidade , Técnicas In Vitro , Masculino , Manitol/química , Manitol/farmacocinética , Pessoa de Meia-Idade , Peso Molecular , Compostos de Tetraetilamônio/química , Compostos de Tetraetilamônio/farmacocinéticaRESUMO
INTRODUCTION: The sclera is considered the 'static barrier,' a main barrier for transscleral drug delivery. The characterization of passive and iontophoretic transport across the sclera in vitro is the first step toward our ability to predict transscleral drug delivery. Although previous studies have investigated this topic, the quantitative structure permeation relationships (QSPR) for passive and iontophoretic transscleral transport are not available. AREAS COVERED: This review evaluated previous results of transscleral passive and iontophoretic transport in vitro and examined QSPR for transscleral permeation of small permeants and macromolecules. Passive permeation data in the literature were compared with respective to the animal species employed in the studies. Data variability was investigated. Electrotransport theory and the mechanisms of iontophoresis were reviewed and used to analyze the iontophoresis data. EXPERT OPINION: QSPR was examined for passive transscleral permeation, showing correlations between logarithm of permeability coefficient and logarithm of molecular weight. Potential causes of data variability were proposed. QSPR were established for electroosmosis using the molecular weight of neutral permeants and for iontophoresis enhancement using the molecular weight and charge of ionic permeants. However, QSPR for charged macromolecules were empirical; iontophoretic flux enhancement was significantly smaller than Nernst-Planck model prediction due to complicating factors.